U.S. Markets closed

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research
Meritor (MTOR) closed the most recent trading day at $23.66, moving +1.41% from the previous trading session.

Investors focused on the Medical space have likely heard of DexCom (DXCM), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of DXCM and the rest of the Medical group's stocks.

DexCom is a member of the Medical sector. This group includes 833 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. DXCM is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for DXCM's full-year earnings has moved 98.22% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

According to our latest data, DXCM has moved about 22.65% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 10.46% on average. This means that DexCom is performing better than its sector in terms of year-to-date returns.

Looking more specifically, DXCM belongs to the Medical - Instruments industry, a group that includes 90 individual stocks and currently sits at #100 in the Zacks Industry Rank. This group has gained an average of 17.95% so far this year, so DXCM is performing better in this area.

Investors in the Medical sector will want to keep a close eye on DXCM as it attempts to continue its solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DexCom, Inc. (DXCM) : Free Stock Analysis Report
To read this article on Zacks.com click here.